{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:54:01Z","timestamp":1761155641492},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/rhu.0b013e31821bfc48","type":"journal-article","created":{"date-parts":[[2012,12,17]],"date-time":"2012-12-17T17:57:41Z","timestamp":1355767061000},"page":"169-172","source":"Crossref","is-referenced-by-count":13,"title":["Rheumatic Complaints in Women Taking Aromatase Inhibitors for Treatment of Hormone-Dependent Breast Cancer"],"prefix":"10.1097","volume":"17","author":[{"given":"Raffaele","family":"Scarpa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Atteno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Padula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Caso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Iervolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Del Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210207","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2005.09.121","article-title":"American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.","volume":"23","author":"Winer","year":"2005","journal-title":"J Clin Oncol"},{"key":"R2-2-20210207","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1200\/JCO.2006.07.5382","article-title":"Aromatase inhibitors and bone health in women with breast cancer.","volume":"24","author":"Chien","year":"2006","journal-title":"J Clin Oncol"},{"key":"R3-2-20210207","first-page":"2767","article-title":"Aromatase inhibitors and arthralgia.","volume":"19","author":"Donnellan","year":"2001","journal-title":"J Clin Oncol"},{"key":"R4-2-20210207","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.","volume":"25","author":"Coates","year":"2007","journal-title":"J Clin Oncol"},{"key":"R5-2-20210207","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","article-title":"Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.","volume":"369","author":"Coombes","year":"2007","journal-title":"Lancet"},{"key":"R6-2-20210207","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jnci\/dji250","article-title":"Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.","volume":"97","author":"Goss","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R7-2-20210207","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"R8-2-20210207","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1200\/JCO.2007.10.7573","article-title":"Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.","volume":"25","author":"Crew","year":"2007","journal-title":"J Clin Oncol"},{"key":"R9-2-20210207","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/ard.2006.066159","article-title":"Will steroidal aromatase inhibitors induce rheumatoid arthritis?","volume":"66","author":"Morel","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R10-2-20210207","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10549-006-9394-6","article-title":"Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging.","volume":"104","author":"Morales","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"R11-2-20210207","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1200\/JCO.2007.15.4005","article-title":"Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome.","volume":"26","author":"Morales","year":"2008","journal-title":"J Clin Oncol"},{"key":"R12-2-20210207","first-page":"137","article-title":"Early psoriatic arthritis: the clinical spectrum.","volume":"35","author":"Scarpa","year":"2008","journal-title":"J Rheumatol"},{"key":"R14-2-20210207","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/rheumatology\/23.4.246","article-title":"Psoriatic arthritis in psoriatic patients.","volume":"23","author":"Scarpa","year":"1984","journal-title":"Br J Rheumatol"},{"key":"R15-2-20210207","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.62.2.127","article-title":"Assessment of enthesitis in ankylosing spondylitis.","volume":"62","author":"Heuft-Dorenbosch","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R16-2-20210207","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R17-2-20210207","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1470-2045(08)70182-7","article-title":"Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.","volume":"9","author":"Sestak","year":"2008","journal-title":"Lancet Oncol"},{"key":"R18-2-20210207","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mce.2007.08.014","article-title":"17beta-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytes.","volume":"279","author":"Kramer","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"R19-2-20210207","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/jir.1998.18.219","article-title":"Transgenic mice expressing a truncated Peromyscus leucopus TNF-alpha gene manifest in arthritis resembling ankylosing spondylitis.","volume":"18","author":"Crew","year":"1998","journal-title":"J Interferon Cytokine Res"},{"key":"R20-2-20210207","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/ard.2003.011023","article-title":"Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review.","volume":"62","author":"Keller","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R21-2-20210207","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1185\/030079903125002847","article-title":"Tumor necrosis factor-alpha levels in aqueous humour and serum from patients with uveitis: the involvement of HLA-B27.","volume":"20","author":"Perez-Guijo","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"R22-2-20210207","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1259\/img.15.4.150286","article-title":"Imaging in rheumatology.","volume":"15","author":"Grainger","year":"2003","journal-title":"Imaging"},{"key":"R23-2-20210207","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1470-2045(08)70217-1","article-title":"Role of estrogen in the development of joint symptoms?","volume":"9","author":"Tan","year":"2008","journal-title":"Lancet Oncol"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RHU.0b013e31821bfc48","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:55:49Z","timestamp":1620971749000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-201106000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e31821bfc48","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}